Two Sigma Investments’s Immunovant IMVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-6,331
Closed -$205K 3084
2024
Q1
$205K Sell
6,331
-72,768
-92% -$2.35M ﹤0.01% 2639
2023
Q4
$3.33M Sell
79,099
-267,297
-77% -$11.3M 0.01% 1142
2023
Q3
$13.3M Sell
346,396
-663,087
-66% -$25.5M 0.04% 474
2023
Q2
$19.1M Buy
1,009,483
+36,613
+4% +$695K 0.05% 388
2023
Q1
$15.1M Buy
972,870
+615,833
+172% +$9.55M 0.04% 429
2022
Q4
$6.34M Buy
357,037
+98,470
+38% +$1.75M 0.02% 719
2022
Q3
$1.44M Sell
258,567
-291,816
-53% -$1.63M ﹤0.01% 1264
2022
Q2
$2.15M Sell
550,383
-271,486
-33% -$1.06M 0.01% 1118
2022
Q1
$4.53M Sell
821,869
-31,659
-4% -$174K 0.01% 942
2021
Q4
$7.27M Sell
853,528
-290,783
-25% -$2.48M 0.02% 763
2021
Q3
$9.94M Sell
1,144,311
-130,838
-10% -$1.14M 0.02% 599
2021
Q2
$13.5M Buy
1,275,149
+504,584
+65% +$5.33M 0.03% 540
2021
Q1
$12.4M Buy
770,565
+737,829
+2,254% +$11.8M 0.03% 513
2020
Q4
$1.51M Sell
32,736
-27,609
-46% -$1.28M ﹤0.01% 1186
2020
Q3
$2.12M Buy
60,345
+51,198
+560% +$1.8M 0.01% 894
2020
Q2
$223K Buy
+9,147
New +$223K ﹤0.01% 1716